193 related articles for article (PubMed ID: 9917086)
1. Combination antifungal therapy for invasive aspergillosis infection in liver transplant recipients: report of two patients.
Bajjoka IE; Bailey EM; Vazquez JA; Abouljoud MS
Pharmacotherapy; 1999 Jan; 19(1):118-23. PubMed ID: 9917086
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary resection for invasive Aspergillus infections in immunocompromised patients.
Robinson LA; Reed EC; Galbraith TA; Alonso A; Moulton AL; Fleming WH
J Thorac Cardiovasc Surg; 1995 Jun; 109(6):1182-96; discussion 1196-7. PubMed ID: 7776682
[TBL] [Abstract][Full Text] [Related]
3. [Aspergillosis in pulmonary transplantation].
de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and treatment of invasive aspergillosis infection following orthotopic liver transplantation].
Yi SH; Chen GH; Lu MQ; Yang Y; Cai CJ; Xu C; Li H; Wang GS; Yi HM
Zhonghua Wai Ke Za Zhi; 2006 Jul; 44(13):885-8. PubMed ID: 17067477
[TBL] [Abstract][Full Text] [Related]
5. Itraconazole for the treatment of pulmonary aspergillosis in heart transplant recipients.
Nanas JN; Saroglou G; Anastasiou-Nana MI; Kostis EB; Petrochilou-Paschou VP; Kontoyannis DA; Stamatelopoulos SF; Moulopoulos SD
Clin Transplant; 1998 Feb; 12(1):30-4. PubMed ID: 9541420
[TBL] [Abstract][Full Text] [Related]
6. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
Patterson TF; Kirkpatrick WR; White M; Hiemenz JW; Wingard JR; Dupont B; Rinaldi MG; Stevens DA; Graybill JR
Medicine (Baltimore); 2000 Jul; 79(4):250-60. PubMed ID: 10941354
[TBL] [Abstract][Full Text] [Related]
7. Control of invasive pulmonary aspergillosis with oral itraconazole in a bone marrow transplant patient.
Denning DW; Stepan DE; Blume KG; Stevens DA
J Infect; 1992 Jan; 24(1):73-9. PubMed ID: 1312563
[TBL] [Abstract][Full Text] [Related]
8. Invasive pulmonary aspergillosis after liver transplantation: rapid and complete response to combined and sequential antifungal therapy.
Can MF; Yagci G; Gorenek L; Tozkoparan E; Ozerhan I; Cetiner S
Surg Infect (Larchmt); 2008 Feb; 9(1):99-104. PubMed ID: 18363474
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
[TBL] [Abstract][Full Text] [Related]
10. Invasive pulmonary aspergillosis due to Aspergillus lentulus: Successful treatment of a liver transplant patient.
Yoshida H; Seki M; Umeyama T; Urai M; Kinjo Y; Nishi I; Toyokawa M; Kaneko Y; Ohno H; Miyazaki Y; Tomono K
J Infect Chemother; 2015 Jun; 21(6):479-81. PubMed ID: 25828927
[TBL] [Abstract][Full Text] [Related]
11. Therapy of invasive aspergillosis with itraconazole: improvement of therapeutic efficacy by early diagnosis.
Kreisel W; Köchling G; von Schilling C; Azemar M; Kurzweil B; Dölken G; Lindemann A; Blum U; Windfuhr M; Müller J
Mycoses; 1991; 34(9-10):385-94. PubMed ID: 1668178
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
Izumikawa K; Ohtsu Y; Kawabata M; Takaya H; Miyamoto A; Sakamoto S; Kishi K; Tsuboi E; Homma S; Yoshimura K
Med Mycol; 2007 May; 45(3):273-8. PubMed ID: 17464848
[TBL] [Abstract][Full Text] [Related]
13. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.
Stevens DA; Kan VL; Judson MA; Morrison VA; Dummer S; Denning DW; Bennett JE; Walsh TJ; Patterson TF; Pankey GA
Clin Infect Dis; 2000 Apr; 30(4):696-709. PubMed ID: 10770732
[TBL] [Abstract][Full Text] [Related]
14. Surgical therapy for pulmonary aspergillosis in immunocompromised patients.
Salerno CT; Ouyang DW; Pederson TS; Larson DM; Shake JP; Johnson EM; Maddaus MA
Ann Thorac Surg; 1998 May; 65(5):1415-9. PubMed ID: 9594877
[TBL] [Abstract][Full Text] [Related]
15. Nebulized liposomal amphotericin B and combined systemic antifungal therapy for the treatment of severe pulmonary aspergillosis after allogeneic hematopoietic stem cell transplant for a fatal mitochondrial disorder.
Castagnola E; Moresco L; Cappelli B; Cuzzubbo D; Moroni C; Lanino E; Faraci M
J Chemother; 2007 Jun; 19(3):339-42. PubMed ID: 17594932
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of invasive aspergillosis: review].
Belousov DIu; Maneshina OA
Antibiot Khimioter; 2006; 51(3-4):26-46. PubMed ID: 17165258
[No Abstract] [Full Text] [Related]
17. Itraconazole--perspectives for the management of invasive aspergillosis.
Groll AH
Mycoses; 2002; 45 Suppl 3():48-55. PubMed ID: 12690972
[TBL] [Abstract][Full Text] [Related]
18. Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
Wieland T; Liebold A; Jagiello M; Retzl G; Birnbaum DE
J Heart Lung Transplant; 2005 Jan; 24(1):102-4. PubMed ID: 15653389
[TBL] [Abstract][Full Text] [Related]
19. Aspergillosis in liver transplant recipients: successful treatment and improved survival using a multistep approach.
Duchini A; Redfield DC; McHutchison JG; Brunson ME; Pockros PJ
South Med J; 2002 Aug; 95(8):897-9. PubMed ID: 12190228
[TBL] [Abstract][Full Text] [Related]
20. [Curative treatment of invasive aspergillosis].
Dupont B
Pathol Biol (Paris); 1994 Sep; 42(7):688-93. PubMed ID: 7877863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]